<DOC>
	<DOCNO>NCT00528671</DOCNO>
	<brief_summary>We aim investiagte whether low dose self management oral anticoagulation superior low dose oral anticoagulation order prevent bleed event patient undergo mechanuical heart valve replacement .</brief_summary>
	<brief_title>Very Low Dose Oral Anticoagulation Thromboembolic Bleeding Complications</brief_title>
	<detailed_description>In mechanical heart valve recipient , self-management oral anticoagulation reduce risk develop thromboembolic event improve long-term survival compare international normalize ratio ( INR ) control general practitioner . Low-dose INR self-management ( INR value 1.8.-2.8 aortic valve recipient 2.5 - 3.5 mitral double valve recipient ) increase risk thromboembolic event compare conventional dose INR self-management . Even patient low INR target range , however , risk bleeding event still high risk thromboembolism . We therefore perform prospective , randomized trial 1,800 patient mechanical heart valve replacement . During first six postoperative month , low dose INR self-management perform patient ( INR measurement week ) . Thereafter , 600 patient continue treatment regimen , whereas 1,200 patient perform low dose oral anticoagulation . Out 1,200 patient , 600 perform INR measurement week 600 patient perform INR measurement twice week . Patients follow 24 month .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Phenprocoumon</mesh_term>
	<criteria>Mechanical heart valve recipient Contraindication phenprocoumon Ulcerous disease bleeding tendency , Hypo hypercoagulability Dementia Missing inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>phenprocoumon</keyword>
	<keyword>INR self-management</keyword>
	<keyword>mechanical heart valve replacement</keyword>
	<keyword>bleeding</keyword>
	<keyword>thromboembolism</keyword>
</DOC>